Non-invasive Prenatal Testing A guide for parents-to-be

Similar documents
your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing.

A test your patients can trust.

A test your patients can trust. A company you know and trust.

Each person normally has 23 pairs of chromosomes, or 46 in all. We inherit one chromosome per pair from our mother and one from our father.

Non-Invasive Prenatal Testing (NIPT) Factsheet

Trisomy 13 (also called Patau s syndrome or T13)

Prenatal screening and diagnostic tests

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

First Trimester Screening for Down Syndrome

Prenatal Testing Special tests for your baby during pregnancy

A Guide to Prenatal Genetic Testing

Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA

Sequencing-based Tests to Determine Trisomy 21 from Maternal Plasma DNA

Executive summary. Current prenatal screening

MASSIVELY PARALLEL SEQUENCING OF MATE RNAL PLASMA DNA IN 113 CASES OF FETAL NUCHAL CYSTIC HYGROMA

Clinical Studies Abstract Booklet

Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell- Free Fetal DNA

Obstetrical Ultrasound and Prenatal Diagnostic Center

Fluorescence in situ hybridisation (FISH)

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

The California Prenatal Screening Program

Chromosomes, Mapping, and the Meiosis Inheritance Connection

REI Pearls: Pitfalls of Genetic Testing in Miscarriage

Supporting Information

Prenatal screening January 2015

Fact Sheet 14 EPIGENETICS

Array Comparative Genomic Hybridisation (CGH)

Genetic Counseling: A Profession in the Making. Jessica Hooks, MS Genetic Counselor University of South Carolina

Carrier detection tests and prenatal diagnosis

Patient information on soft markers

Basic Human Genetics: Reproductive Health and Chromosome Abnormalities

Genetics and Pregnancy Loss

Information on the anomaly scan

COMMITTEE OPINION. Cell-free DNA Screening for Fetal Aneuploidy

National Down Syndrome Society

Developing Human Fetus

The costs of having a baby. Private system

In most developed countries, prenatal screening

Non-invasive prenatal detection of chromosome aneuploidies using next generation sequencing: First steps towards clinical application

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

Why is prematurity a concern?

The quadruple test screening for Down s syndrome and spina bifida

Patient & Family Guide Pre-Existing Diabetes and Pregnancy

Alcohol and drugs Be proactive

Genetic Aspects of Mental Retardation and Developmental Disabilities

Optional Tests Offered Before and During Pregnancy

The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands

UNIT 13 (OPTION) Genetic Abnormalities

Communicating with Families about Family History and Genetics

Mother s blood test to check her unborn baby s blood group

The correct answer is c A. Answer a is incorrect. The white-eye gene must be recessive since heterozygous females have red eyes.

CAGC Certification Logbook of Clinical Experience INSTRUCTIONS

Ultrasound scans in pregnancy

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

Prenatal screening and diagnosis of chromosomal and genetic abnormalities in the fetus in pregnancy

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

3/31/2015. Objectives. Alcohol. Long term effects. Substance abuse increases the risk of: Substance Abuse in Pregnancy

The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report

RECURRENT PREGNANCY LOSS DR.RAJALAKSHMI SRINIVASAN SPECIALIST GYNECOLOGIST ZULEKHA HOSPITAL DUBAI

Chromosomes, Karyotyping, and Abnormalities (Learning Objectives) Learn the components and parts of a metaphase chromosome.

Overview of Genetic Testing and Screening

Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood

In - Vitro Fertilization Handbook

Genetic Testing in Research & Healthcare

Neural tube defects: open spina bifida (also called spina bifida cystica)

Alana Obstetrics A familiar face to deliver your baby..

Facts about Congenital Heart Defects

Gutenberg Center in MALAGA

Who Is Involved in Your Care?

4.2 Meiosis. Meiosis is a reduction division. Assessment statements. The process of meiosis

Current Status in Non-Invasive Prenatal Detection of Down Syndrome, Trisomy 18, and Trisomy 13 Using Cell-Free DNA in Maternal Plasma

fi АУ : fi apple Ав Ав АУ . apple, АУ fiав Ав. АК applefi АУ, АУАв Ав fi АУ apple fi Ав. А applefi АУ АУ АУ АсА» Ас Ам, длappleapple Ас...

35-40% of GBS disease occurs in the elderly or in adults with chronic medical conditions.

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates

cfdna in maternal plasma obtained from a population undergoing routine screening at weeks gestation.

Important facts to remember

Balanced. translocations. rarechromo.org. Support and Information

X Linked Inheritance

AUSTRALIA AND NEW ZEALAND FACTSHEET

Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.

Science 10-Biology Activity 15 The Development of the Human Embryo

A Parent s Guide to Understanding Congenital Hypothyroidism. Children s of Alabama Department of Pediatric Endocrinology

Robertsonian Translocations

PREGNANCY INFORMATION PACK. Peace of mind throughout pregnancy

Careful collection, organization and review of medical information

Maternity Renal Pelvis Dilation (RPD)

Mycophenolate mofetil (CellCept ): risks of miscarriage and birth defects. Patient guide. Key points to remember

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016

GSCE CHILD DEVELOPMENT: REVISION TIPS!

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

INTELLIGENCE. Key: Alfred Binet. Key: William stern.

Trisomies 13 and 18. -Maternal age. (Patau and Edward s syndrome)

Chromosomal Abnormalities

Speech Pathology Funding Information for Clients

Rh D Immunoglobulin (Anti-D)

Molar pregnancy. (hydatidiform mole)

Neural Tube Defects - NTDs

Genetics in Family Medicine: The Australian Handbook for General Practitioners Testing and pregnancy

Cover for pregnancy and childbirth

Transcription:

Generation TM Non-invasive Prenatal Testing A guide for parents-to-be

A revolutionary advance What is the Generation TM non-invasive prenatal test? Non-invasive prenatal testing (NIPT) is a revolutionary advance in prenatal screening which can detect genetic material (DNA) from the placenta in a blood test from the mother. In the past, the ability to test DNA from the fetus required much more invasive methods such as amniocentesis or placental biopsies, which are not without risks to mothers and their babies. NIPT is a simple and highly accurate test which may help avoid more invasive techniques of prenatal testing. The Generation non-invasive prenatal test (NIPT) screens for the most common chromosomal abnormalities that can affect your baby s future health using a simple blood test. The Generation NIPT is available from as early as the 10th week of pregnancy, for both singleton and twin pregnancies. How does the Generation TM test work? During pregnancy, some of the baby s DNA from the placenta crosses into your bloodstream. A sample of your blood is drawn from you, and the Generation NIPT tests this DNA to identify certain chromosome conditions in your pregnancy. The Generation test takes a deeper approach to the science, using an advanced technology called Massively Parallel Sequencing to analyse millions of DNA fragments per sample and accurately count the number of chromosomes present and determine if there are too many or too few copies of the tested chromosomes in your baby.

in prenatal screening simple, safe, true. Is the Generation TM test right for me? The Generation test offers parents-to-be a new choice to obtain important information about the health of their developing baby, simply, accurately and in the first trimester (at 10 weeks), with little or no risk to their pregnancy. This screening test may be an option for you to consider if: You are 35 years or older at the time of delivery (32 years or older for a twin pregnancy) You have an abnormal or positive serum screen Your ultrasound shows concerns or abnormalities with fetal growth and/or development You have a personal or family history suggestive of a chromosome disorder (e.g. Down syndrome)

Accurate answers about What kind of conditions can the Generation TM test detect? Chromosomes normally come in pairs. Healthy people have 23 pairs of chromosomes, with one pair which determines sex. Men normally have an XY pair of sex chromosomes, and women normally have an XX pair of sex chromosomes. Any more or less can lead to mental or physical disabilities, with different levels of severity. The Generation NIPT looks for too few (missing) or too many (extra) copies of chromosomes, which are often associated with these disabilities. The most commonly seen and tested for include an extra copy of chromosome 21 (Down syndrome), or an extra copy of chromosome 18 (Edwards syndrome), or chromosome 13 (Patau syndrome), all of which can be accurately detected with the Generation test. If you and your healthcare provider choose it, the Generation TM prenatal test can also be used to screen for the following genetic conditions: Sex chromosome abnormalities, such as Turner syndrome (only one X chromosome in a female) or Klinefelter syndrome (an extra X chromosome in a male), or Triple X and Jacobs syndrome (an extra Y chromosome in a male). Trisomy 9, which is caused by an extra copy of chromosome 9. Almost all pregnancies with trisomy 9 end in first trimester miscarriage. Pregnancies with partial trisomy 9 may survive until term, but typically have significant birth defects and intellectual disabilities. Trisomy 16, which is caused by an extra copy of chromosome 16. Trisomy 16 is one of the most common causes of miscarriage. Pregnancies with

your baby s health simple, safe, true. partial trisomy 16 may survive until term, but are at increased risk for pregnancy complications and often have significant birth defects and intellectual disabilities. Common microdeletions, which are caused by the loss of a small piece of a chromosome. Some of the common microdeletions which can be detected by the Generation test include: DiGeorge syndrome (22q11.2 deletion syndrome), which is commonly associated with heart defects, cleft palate, immune system disorders and intellectual disabilities. Angelman syndrome, which is commonly associated with significant developmental delay and learning disabilities, seizures and hyperactivity. Prader-Willi syndrome, which is commonly associated with mild to moderate intellectual disabilities, poor muscle tone and feeding difficulties in infancy that progresses to behaviour issues and compulsive over-eating in childhood. Wolf-Hirschhorn syndrome, which is associated with intellectual disability, characteristic facial features, seizures and delayed growth and development. Cri-du-chat syndrome, which is associated with intellectual disability, developmental delays, characteristic facial features and a high-pitched, cat-like cry in newborns.

The honesty you seek Why should I choose the Generation TM test over other tests? Compared to similar options, the Generation prenatal test offers accurate, near diagnostic information, rather than calculating chances or risk scores. It does not carry the risk of complications that an invasive procedure can. It s simple. A single tube of blood drawn from your arm; It s convenient. You can have blood collected in one of our collection centres from as early as 10 weeks; It s accurate 1,2,5. Observed Sensitivity Observed Specificity Trisomy 21 99.1% 99.9% Trisomy 18 98.3% 99.9% Trisomy 13 98.2% 99.9% Monosomy X 95.0% 99.0% XX 97.6% 99.2% XY 99.1% 98.9% It s tested in Australia. It s reliable. It has the lowest test failure of any NIPT (0.1%) 1 ; 0.1% Test Failure Rate It s fast. Your healthcare provider will receive results within 3-7 business days from receipt in our laboratory.

with superior technology simple, safe, true. How will my test be reported? Your test report will include one of three possible results for chromosomes 21, 18, and 13: 1 No Aneuploidy Detected means the expected number of chromosomes was found 2 Aneuploidy Detected means too many or too few copies of one of the chromosomes have been identified. A diagnostic test for confirmation is recommended and should be discussed by your doctor 3 Aneuploidy Suspected a borderline result, which occurs very rarely. This suggests there might be too many (or too few) copies of a chromosome present. Your provider may advise a diagnostic test for confirmation If the sex chromosome option is ordered, results will be reported as either No Aneuploidy Detected or Aneuploidy Detected. Do normal Generation TM test results mean that my baby will be perfectly healthy? The Generation prenatal test is a highly accurate advanced screening test that is non-invasive. No test, however, can guarantee a baby will not have any medical issues. The Generation test only addresses aneuploidies of chromosomes 21, 18, 13, and sex chromosomes, if ordered. It does not test for, or report all, genetic and non-genetic problems that may be present in a baby. Sex chromosome aneuploidy testing is available for singleton pregnancies only

Results you can trust How do I know I can trust the Generation TM test? The Generation test was chosen for development by Genomic Diagnostics based on a careful evaluation of its quality and proven scientific performance. The performance of the Generation prenatal test has been evaluated and published in numerous major studies, including clinical experience in over 34,000 patients from over 60 leading US medical research and teaching institutions 1. Those findings have subsequently been replicated in other studies 2, 3, 4, including the New England Journal of Medicine, one of the most prestigious international medical journals. These studies have found that the test performed substantially better than conventional tests under regular clinical conditions, with ~1 in 4,000 false negative results, ~1 in 500 false positive results, and the lowest test failure rate of any non-invasive prenatal test. Your tests are performed in Australia in an accredited Australian laboratory, with this test undergoing full regulatory evaluation in the coming months.

with proven studies 1,2,3,4 simple, safe, true. How do I organise to have the test? 2. Complete the request form with your doctor (go to genomicdiagnostics. com.au) 4. Bring the documents to your appointment. Your blood sample will be taken and sent to the lab for testing 6. Your results are delivered to your medical practitioner 1 2 3 4 5 6 1. Make an appointment to see your medical practitioner and discuss the Generation NIPT 3. Contact our Customer Care Team on 1800 822 999 to make a booking at one of our conveniently located collection centres 5. Your Generation NIPT is performed

Results you can trust

simple, safe, true. Does Medicare or private health insurance cover the cost of the Generation TM prenatal test? The Generation prenatal test does not qualify for a Medicare rebate. The total out-of-pocket cost to the patient for the standard test for chromosomes 13, 18, and 21 is $395*, which is payable at the time of making your appointment. When testing for additional chromosome regions, extra fees will apply. To learn more about the Generation prenatal test, please visit www.genomicdiagnostics.com.au References 1. Bhatt S, Parsa S, Snyder H, et al. Clinical Laboratory Experience with Noninvasive Prenatal Testing: Update on Clinically Relevant Metrics. ISPD 2014 poster. 2. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890 901. 3. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in non-invasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013;33:569-574. 4. Bianchi DW, Parker RL, Wentworth J et al. DNA Sequencing versus Standard Prenatal Aneuploidy Screening. N Engl J Med 2014; 370:799-808. 5. Verinata Health, Inc. (2012) Analytical Validation of the verifi Prenatal Test: Enhanced Test Performance For Detecting Trisomies 21, 18 and 13 and the Option for Classification of Sex Chromosome Status. Redwood City, CA. TM

TM The honesty you seek simple, safe, true A simple, one tube blood test Safe from procedural risks of invasive procedures (amniocentesis/cvs) Lowest test failure rate among non-invasive prenatal tests Fast results usually available to your doctor within 3-7 days from receipt in our lab To learn more about the Generation prenatal test please call 1800 822 999 or visit genomicdiagnostics.com.au *Prices are correct at time of printing and are subject to change without notice. As this brochure contains only general information, professional advice from your medical practitioner should be sought before applying the information in this brochure to particular circumstances. You should not rely on any information contained in this brochure without first obtaining professional advice. Specialist Diagnostic Services Pty Ltd (ABN 84 007 190 043) t/a QML Pathology PUB/MR/1339, v2 (Mar-16)